Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Anti Kickback
Insys Agrees to Settlement Regarding Opioid Sales Probe
On Wednesday, August 8, 2018, Insys Therapeutics announced a deal to pay $150 million to resolve the United States Department of…
Azar Continues to Promote Administration Drug Pricing Policy, Plus RFI…
On June 26, 2018, the Senate Finance Committee held a hearing to examine President Donald Trump’s plan to lower prescription drug…
Former Valeant Executive Found Guilty of Anti-Kickback Violations
Valeant Pharmaceuticals, Inc. has had a bumpy three years due to allegations of executive bribes and mismanagement. The most…
Insys: The Hits, They Just Keep Coming – One Rep Pleads Guilty to…
We have previously written about Insys founder John Kapoor and other executives that have found themselves in hot water regarding…
Federal Grand Jury Indicts Three in Opioid Scheme
With the opioid crisis rapidly gaining steam, we are starting to see some of the legal ramifications from the overprescribing of…
Maine Updates Their Gift to Physicians Law Online
Maine has posted a revised version of their gifts to physicians law which bans cash payments from pharmaceutical manufacturers,…
New Jersey Finalizes “Gift” Ban of Physicians Working with the…
In an unusual administrative move – without passing any new laws – on December 22, 2017, the Attorney General of New Jersey…
Will Your Whistle Be Heard at Home?
The distinct split between the Second and Fifth Circuit Courts’ interpretation as to when whistleblower protections are allowed…
Founder and Owner of Insys Arrested
Late last week, John N. Kapoor, the founder and majority owner of Insys Therapeutics, Inc., was arrested and charged with leading…
The EpiPen Whistleblower Saga Comes to a Close
Last week, Mylan Inc. and Mylan Specialty L.P. (hereinafter “Mylan”) reached an agreement with the United States Department of…